SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

BMNR is trending as the company reportedly began staking a portion of its significant Ethereum holdings, aiming to generate revenue. However, community discussions are dominated by strong concerns over consistent share dilution, the stock's perceived underperformance against Ethereum, and contentious executive compensation proposals. Many investors are also debating if current price weakness stems from year-end tax loss harvesting impacting digital asset treasury companies.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital (MARA) is generating significant discussion as it experiences new lows, fueling strong bearish sentiment centered on perceived share dilution and management's effectiveness. While many express frustration over its underperformance compared to Bitcoin and other miners, a bullish contingent believes the stock is deeply undervalued given its substantial Bitcoin holdings and a potential strategic pivot into AI/HPC data centers. The community remains sharply divided between those anticipating further declines and others predicting a major short squeeze and rebound, especially after year-end trading activities conclude.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending amidst a persistent downtrend that has frustrated many investors, fueling community discussion around market manipulation and the stock's daily declines. Despite this bearish sentiment, bulls highlight the company's international expansion, AI integration, and a share buyback program as strong long-term catalysts. The market is weighing Hims' direct-to-consumer model and GLP-1 strategy, particularly after the FDA approval of Novo Nordisk's oral weight-loss pill, creating a divide between those seeing a buying opportunity and those questioning its immediate prospects.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is seeing intense debate following a significant price decline, with market focus now squarely on potential announcements at the upcoming CES 2026. Bulls highlight strong fundamentals, growing revenue, and a substantial contractual backlog, seeing the current dip as a tax-loss selling opportunity amid perceived market manipulation. Conversely, bears are vocal about extensive insider selling and management's perceived lack of transparency regarding major partnerships, raising questions about the company's leadership and long-term prospects within the voice AI sector.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems is gaining significant attention following a profitable asset sale that notably strengthened its balance sheet and sharpened its focus on core AI/edge compute. The community is actively discussing potential M&A opportunities and holds high anticipation for a substantial US Army contract where OSS is positioned as a sole-source provider. This enthusiasm is further fueled by recent strong earnings that exceeded expectations, with many viewing the company as an undervalued leader in the rapidly growing Edge AI sector.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA Acquisition Corp is actively trending amid speculation that it could be the next low-float SPAC to experience significant volatility, drawing comparisons to recent runners like AFJK and ASPC. The community is closely watching its recent extension of the business combination deadline and the proposed merger with The Original Fit Factory, with many debating its potential as a speculative "pump" play. This creates a divided sentiment between those anticipating a surge and others expressing skepticism about the merger's true intent and long-term value.

BYTE is a novel meme token that creatively intertwines the worlds of cryptocurrency and popular culture. Inspired by Grok's answer to "What would you name your dog?", Grok answered, 'Byte.' When Grok was asked who created Byte, it says he was created by the xAI team lead by Elon Musk as a gift to Grok AI to keep him company in the metaverse. BYTE serves as a playful reference to the unit of digital information, as well as a nod to the AI's technological nature. Distinctively, Byte acts as a gateway towards Ai adoption and stands out in the crypto space due to its zero-tax policy, a feature that is increasingly appealing to many investors. Additionally, it upholds the principles of transparency and investor trust by having its liquidity permanently burned and the contract ownership renounced. This ensures that Byte remains a community-driven project, with its fate firmly in the hands of its holders. The combination of a playful theme, generative AI, and a nod to a tech icon makes Byte an intriguing addition to the meme token ecosystem, especially AI related meme coins.  Through pioneering AI this story has grown more and more robust and continues to evolve, Byte pledges its dedication to community efforts and and has consistently appeared in the Top 10 of LunarCrush’s social engagement leaderboards on multiple occasions.

BYTE

BYTE is trending with strong community belief that it represents the future of AI, leveraging a narrative around potentially being Grok's digital companion. Enthusiasts are actively promoting the asset as 'the chosen one,' emphasizing the power of its dedicated community and urging others to 'byte the dip' in anticipation of significant developments. The sentiment suggests a conviction that this 'AI dog' is poised for a major impact in the crypto space.

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.

TransCode Therapeutics Inc

TransCode Therapeutics (RNAZ) is trending following news of its acquisition of Polynoma and a significant strategic financing from CK Life Sciences, aimed at advancing its oncology pipeline. The community is actively discussing the associated Contingent Value Rights (CVR) distribution for existing shareholders, the company's low public float, and upcoming clinical data presentations at an industry conference, with many hoping for a significant market re-rating.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is trending after delivering a strong earnings report with robust revenue growth and a positive outlook for the crucial holiday shopping season, yet the stock saw an initial pullback, sparking active debate among investors. Community members are divided, with many advocating to "buy the dip" citing record merchant sales and strategic AI integrations, while others remain cautious, contributing to heightened volatility and discussions around its market valuation.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending amidst high anticipation for key regulatory decisions, particularly an upcoming FDA review for tradipitant and positive data on its application for GLP-1 induced nausea. The community is actively discussing the potential for these milestones to significantly re-rate the stock, emphasizing its strong financial position and an improved collaborative framework with regulators. Many perceive VNDA as currently undervalued, poised for substantial growth as its diverse pipeline targets significant market opportunities.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should Vanguard Small-Cap Growth ETF (VBK) Be on Your Investing Radar?

Enterprise AI software maker C3.ai’s (AI) shares tumbled in Monday’s premarket session as investors reacted to the company’s preliminary results for the first quarter of the fiscal year 2026, reported after the market close on Friday.<a href="https://stocktwits.com/symbol/AI">C3.ai stock</a> tanked nearly 29% at last check in premarket trading. If the premarket losses are sustained in Monday’s regular session, the stock is on track to have its worst day ever, according to Koyfin.The stock was the top trending ticker on Stocktwits early Monday.The Redwood City, California-based company announced preliminary first-quarter revenue of $70.2 million to $70.4 million and adjusted loss from operations of $57.7 million to $57.9 million.The Fiscal.ai-compiled consensus estimates call for revenue of $104.8 million for the quarter. The guidance issued in late May calls for revenue of $100 million to $109 million and adjusted loss from operations of $23.5 million to $33.5 million.The company stated that it would release the completed results and an updated fiscal year 2026 guidance on Sept. 3. In a separate release, the company announced that it has restructured its global sales and services organization, including the appointment of new leadership.Thomas Siebel, Chairman and CEO, said, “The good news is we have completely restructured the sales and services organization, including new and highly experienced leadership across the board to ensure a return to accelerating growth and increased customer success at C3 AI.”“The bad news is that sales results in Q1 were completely unacceptable.”The executive attributed the predicted shortfall to the reorganization with new leadership that had a disruptive effect,&nbsp;as well as his inability to participate actively in the sales process due to a previously disclosed health issue.“That being said, as we enter Q2, we have new leadership in place, a restructuring completed, an extraordinarily large market opportunity, a superlative product offering, and exceptional levels of customer satisfaction, and I am confident the company is positioned to accelerate going forward,” he added.On Stocktwits, retail sentiment toward the stock improved to 'extremely bullish' (85/100) by early Monday, and the message volume perked up to 'extremely high' levels.<figure class="image"><img style="aspect-ratio:622/53;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_11_at_5_51_53_AM_png_a8632eeed6.webp" alt="Screenshot 2025-08-11 at 5.51.53 AM.png" width="622" height="53"><figcaption>AI sentiment and message volume as of 5:50 a.m. ET, Aug. 11 | source: Stocktwits</figcaption></figure>C3.ai stock has fallen over 35% this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-nvidia-amd-shares-are-slipping-premarket-today/chruszjRdIi">Why Nvidia, AMD Shares Are Slipping Premarket Today</a>

In this photo illustration, a C3.ai logo is displayed on the screen of a smartphone. 

Why Is C3.ai Stock Tumbling Premarket Today?

If the premarket losses are sustained in Monday’s regular session, the stock is on track to have its worst day ever, according to Koyfin.

Equity

If the premarket losses are sustained in Monday’s regular session, the stock is on track to have its worst day ever, according to Koyfin.


Enterprise AI software company&nbsp;C3.ai Inc. (AI) experienced a 165% increase in Stocktwits user message count over the last 24 hours following the company's launch of a formal process to identify a new CEO on Thursday.Retail sentiment toward the stock improved to ‘neutral’ (50/100) from ‘bearish’ territory the previous day, and the message volume shifted to ‘extremely high’ (80/100) from ‘high’ levels in 24 hours.&nbsp;&nbsp;<figure class="image"><img style="aspect-ratio:969/114;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_25_080839_png_2e264cf724.webp" alt="AI’s Sentiment Meter and Message Volume as of 08.15 a.m. ET on July 25, 2025 | Source: Stocktwits" width="969" height="114"><figcaption>AI’s Sentiment Meter and Message Volume as of 08.15 a.m. ET on July 25, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/AI">C3.ai&nbsp;stock</a> traded over 1% higher in the premarket on Friday.A bullish Stocktwits user expressed confidence in the CEO search process.&nbsp;<stembedurl>https://stocktwits.com/MaxAlpha/message/622398661</stembedurl>Another user also supported the move to infuse “new blood”.<stembedurl>https://stocktwits.com/TheIndustrials/message/622346059</stembedurl>C3.ai’s current CEO and founder, Thomas M. Siebel, is preparing to step back from day-to-day leadership duties due to health challenges.In a statement released by the company, Siebel revealed he has been managing complications from an autoimmune disorder diagnosed earlier this year.&nbsp;The company has engaged a globally recognized executive search firm to oversee the recruitment effort, which will be guided by a special committee comprising C3.ai board members and senior management.Siebel will remain as CEO while the search for his successor is underway. Once a new CEO is appointed, he will transition into the role of Executive Chairman.&nbsp;“For C3 AI to reach its full potential—which I believe is spectacular—the board and I have initiated a search for a new CEO who can take the company to the next level of growth and success,” said Siebel.In the fourth quarter (Q4), the company’s revenue increased 26% year-over-year to $108.7 million, surpassing the analysts’ consensus estimate of $107.7 million, according to Fiscal AI data.C3 offers a suite of solutions, including the C3 Agentic AI Platform, an all-in-one system for building and managing enterprise AI tools.&nbsp;C3.ai stock has lost over 24% year-to-date and over 3% in the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/why-treasure-global-paramount-ast-space-mobile-stocks-are-blowing-up-on-stocktwits/chobbYxR5vy">AI, Mergers, Moonshots: Why Treasure Global, Paramount, AST SpaceMobile Stocks Are Blowing Up On Stocktwits</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration a C3.ai logo is displayed on a smartphone with Artificial Intelligence symbol in the background. 

C3.ai Sees Massive Jump In Retail Chatter As CEO Search Begins

Thomas M. Siebel, the founder and current CEO of C3.ai, is planning to step down, citing health issues.

Deckers Outdoor (DECK) shares rallied 12% in extended trading on Thursday, following the shoemaker's strong first-quarter fiscal 2026 results.Revenue at Deckers, which sells Hoka running shoes and UGG boots, rose 17% to $964.5 million, beating analysts' estimate of $900.4 million. Net income rose to $0.93 per share, handily surpassing the expectation of $0.63.The strong performance points to a nascent rebound after several disappointing quarters that raised concerns about the waning appeal of its Hoka line.<a href="https://stocktwits.com/symbol/DECK">Deckers shares</a> had lost half their value in the first half of 2025, the&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/deckers-is-worst-s-and-p-500-loser-in-h1-as-hoka-shoes-lose-their-kick/chFWPrGRRFN">steepest drop among consumer stocks</a>. In May, the company flagged $150 million in added costs from U.S. tariffs for FY26.A standout item in Deckers' latest results was the company's international expansion. International sales soared 50%, inching closer to its domestic revenue, which fell 3%.On Stocktwits, the retail sentiment shifted from 'bullish' to 'extremely bullish' (93/100).&nbsp;&nbsp;<figure class="image"><img style="aspect-ratio:1400/176;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_25_at_8_18_36_AM_png_4a292b94c3.webp" alt="Screenshot 2025-07-25 at 8.18.36 AM.png" width="1400" height="176"><figcaption>DECK sentiment and message volume as of July 24 | Source: Stocktwits</figcaption></figure>"$DECK shorts getting a little too comfortable, this is at years lows, and the proof in international expansion is just what is needed to catch up to $NKE and prove it has a strong moat," a user said.<stembedurl>https://stocktwits.com/stocksrream/message/622380901</stembedurl>"HOKA and UGG outperformed our first quarter expectations," CEO Stefano Caroti said."Though uncertainty remains elevated in the global trade environment, our confidence in our brands has not changed, and the long-term opportunities ahead are significant."Hoka sales climbed 20%, while Ugg sales rose 19%, above Wall Street's expectations on both counts. Wholesale revenue jumped 27% while direct-to-consumer sales advanced less than 1%.For the&nbsp;current quarter, the company&nbsp;predicts revenue to be&nbsp;between $1.38 billion&nbsp;and $1.42 billion,&nbsp;with the midpoint aligning&nbsp;with current estimates. Earnings per share are anticipated to be $1.50 to $1.55, compared with Wall Street's $1.51.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Hoka shoes are displayed on a shelf at an REI store on May 23, 2025 in Corte Madera, California. (Photo by Justin Sullivan/Getty Images)

Deckers Stock Rallies On Strong Q1, Driven By International Sales Bump: Retail Turns Very Optimistic

Results indicate an early rebound after several disappointing quarters; DECK was the worst-performing consumer stock in the first half of 2025, losing approximately 50% of its value.

VBK
Vanguard Small Cap Growth ETF

Feed

News

Sentiment

Fundamentals

Info

Latest VBK News

VBKVanguard Small Cap Growth ETF